Trial reports myelin repair success

Repairing the damage to nerves caused by MS is possible, according to new research.

A study of the cancer drug bexarotene in Cambridge and Edinburgh showed that it led to the regrowth of myelin in people with relapsing remitting MS. However, the dose needed to produce this effect also led to serious side effects including thyroid disease and potentially damaging levels of blood fats. The results were presented at the MS Virtual conference.

Although the fact that it is possible to encourage the regrowth if myelin in humans is a breakthrough and will leads to further research, the side effects mean that bexarotene will not become a treatment for MS.

The Cambridge team are planning another remyelination study using metformin (a diabetes drug) in combination with clemastine (a treatment for hay fever and allergies)

Find out more

Ponesimod (Ponvory) for relapsing remitting multiple sclerosis rejected by NICE

13 Oct 2021 - 00:00

The MS Trust is very disappointed that NICE does not recommend ponesimod (Ponvory) as an NHS treatment in England and Wales.

Multiple sclerosis and disease modifying drugs, what are my options?

28 Sep 2021 - 00:00

We interview Dr Sharmilee Gnanapavan, a Consultant Neurologist at Bart's Health to get some answers on what's new in the world of disease modifying drugs and multiple sclerosis.

New report highlights barriers to accessing Sativex across the UK

18 Aug 2021 - 00:00

Fewer than 13% of people in England eligible for Sativex can access it, according to a new report published today. People living in Wales, Scotland and Northern Ireland also face difficulties.

Move it for MS Nick's story

7 Oct 2021 - 00:00

Nick, was diagnosed with relapsing remitting multiple sclerosis at the start of the first lockdown. In this story we talk to him about how he coped with his diagnosis and how running helps him with his MS.

David's diary - Inclusion and diversity, where are we now?

6 Oct 2021 - 00:00

Just over a year ago we published a diary entry about Inclusivity and Diversity at the MS Trust. In this piece we take a look at what's changed since then and what we still need to do.

Flu season 2021

4 Oct 2021 - 00:00

This year is likely to involve a bigger flu vaccination programme in the UK, including for people with multiple sclerosis (MS), due to the circulation of Covid-19 at the same time. Here we discuss who's eligible for a flu jab on the NHS and how to get one.